Search alternatives:
significantly improve » significantly improved (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search), improves disease (Expand Search)
Showing 381 - 400 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly improve decrease ))*', query time: 0.59s Refine Results
  1. 381
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  2. 382
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  3. 383
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  4. 384
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  5. 385
    Follow-up after cesarean section reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744.

    Follow-up after cesarean section reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744. by María Jesús Cancelo Hidalgo (12154030)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 386
    Characteristics of complicated cesarean sections reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744.

    Characteristics of complicated cesarean sections reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744. by María Jesús Cancelo Hidalgo (12154030)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 387
    Ranking of factors in order of importance as reported by survey respondents regarding the difficulty in accessing the lower uterine segment (A), complicated fetal extraction in cesarean section (B), and anomalous placentation (C), stratified by hospital level.

    Ranking of factors in order of importance as reported by survey respondents regarding the difficulty in accessing the lower uterine segment (A), complicated fetal extraction in ces... by María Jesús Cancelo Hidalgo (12154030)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 388
    Characteristics of respondents in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744.

    Characteristics of respondents in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744. by María Jesús Cancelo Hidalgo (12154030)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 389
    Intraoperative and postoperative complications of cesarean section reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744.

    Intraoperative and postoperative complications of cesarean section reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744. by María Jesús Cancelo Hidalgo (12154030)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 390
    Characteristics of the action protocols reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744.

    Characteristics of the action protocols reported in the national survey of obstetric protocols and outcomes in Spain (March-June 2024). n = 744. by María Jesús Cancelo Hidalgo (12154030)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 391
    This is the raw data used for this study.

    This is the raw data used for this study. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 392
    Pre-operative versus post-operative symptoms.

    Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 393
    The Human Disharmony Loop (full) Including Inciting Factors.

    The Human Disharmony Loop (full) Including Inciting Factors. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 394
    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup>

    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup> by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 395
    The Human Disharmony Loop Clinical Presentation.

    The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 396
    Patient Demographics.

    Patient Demographics. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 397
    Pain and Function Outcomes Following PM Tenotomy.

    Pain and Function Outcomes Following PM Tenotomy. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 398
    Diagnostic Criteria for Human Disharmony Loop.

    Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 399
    Normal Anatomy vs. Disharmonic Pathoanatomy.

    Normal Anatomy vs. Disharmonic Pathoanatomy. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 400
    The Human Disharmony Loop (central).

    The Human Disharmony Loop (central). by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: